[No standalone website (unbranded, no questionnaire)] A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)

How to apply

Determine if a study site for this clinical trial is near you. Contact the study to apply.

Find a Study Site
Share this article

Study’s contact

Call center

0512143564

Email address

alessio.morganti2@unibo.it

Condition

Analgesic Drugs,Cancer Pain

Treatment type

Observational

Investigational product

Patients accessing to Radiotherapy Unit

Sponsor

Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi

ClinicalTrials.gov identifier

NCT03550599

Study number

ARISE

Understanding clinical trials

Get answers to your questions about clinical trials.

About the study

Aim of the study is to evaluate adequacy of pain treatment in oncologic patients, accessing to Radiotherapy Unit

Who can take part?

You may be eligible to participate in the study if you meet the following criteria:

Inclusion criteria

  1. patients accessing to Radiotherapy Unit for radiation treatment (both palliative or with radical intent) with diagnosis of primitive or metastatic cancer;
Exclusion criteria

  1. Concomitant diseases that can affect reliability of collected data

For a full list of inclusion/exclusion criteria, please visit ClinicalTrials.gov

Study locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to apply

Determine if a study site for this clinical trial is near you. Contact the study to apply.

Find a Study Site